Royalty Pharma Q1 Sales $568.00M Miss $663.22M Estimate
Portfolio Pulse from Benzinga Newsdesk
Royalty Pharma (NASDAQ:RPRX) reported Q1 sales of $568.00M, missing the consensus estimate of $663.22M by 14.36%, marking a 16.96% decrease from the previous year's $684.00M.
May 09, 2024 | 11:02 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Royalty Pharma's Q1 sales of $568.00M missed estimates by 14.36%, a significant decrease from last year's $684.00M.
Missing sales estimates by a significant margin and reporting a notable year-over-year decrease in sales are likely to negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100